| Literature DB >> 23379291 |
Kevin B Temeyer1, Danett K Brake, Alexander P Tuckow, Andrew Y Li, Adalberto A Pérez de León.
Abstract
BACKGROUND: Millions of people and domestic animals around the world are affected by leishmaniasis, a disease caused by various species of flagellated protozoans in the genus Leishmania that are transmitted by several sand fly species. Insecticides are widely used for sand fly population control to try to reduce or interrupt Leishmania transmission. Zoonotic cutaneous leishmaniasis caused by L. major is vectored mainly by Phlebotomus papatasi (Scopoli) in Asia and Africa. Organophosphates comprise a class of insecticides used for sand fly control, which act through the inhibition of acetylcholinesterase (AChE) in the central nervous system. Point mutations producing an altered, insensitive AChE are a major mechanism of organophosphate resistance in insects and preliminary evidence for organophosphate-insensitive AChE has been reported in sand flies. This report describes the identification of complementary DNA for an AChE in P. papatasi and the biochemical characterization of recombinant P. papatasi AChE.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23379291 PMCID: PMC3598880 DOI: 10.1186/1756-3305-6-31
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Oligodeoxynucleotide primers for AChE of
| PpAce18F-273U23 | 1-23 (U) | CAATAACGTGGTATCTCGCATAA |
| PpAChE458U17 | 186-202 (U) | TTGGCGGAGGGTCGTCA |
| PpAChE552U22 | 280-302 (U) | TCTTAGGCGAATCAACATTAGA |
| PpAChE550L23 | 300-278 (L) | CTAATGTTGATTCGCCTAAGACT |
| PpAChE5R-693 L20 | 497-378 (L) | CGCTCCAGTGTGCCCAATTC |
| PpAChE20-828U23 | 827-849 (U) | CTTCGGTGGTGGATTCTACTCAG |
| PpAChEp13-435 L21 | 975-955 (L) | CAGGGGCATCAGGAGTACCAA |
| PpAChEp13-719U18 | 1221-1239 (U) | CTAGCCGAAGCCGTGGAG |
| PpAChE7Jan-590 L22 | 1226-1205 (L) | GGCTAGGCGAAGGGTTCTATTG |
| PpAChE7J-887U23 | 1502-1524 (U) | AGAGGAGGGCATAACTGTAACAC |
| PpAChE7J-947 L22 | 1582-1562 (L) | CGCACGGCACCATTGACATAG |
| PpAChE7J-1100U22 | 1715-1736 (U) | TGAGGAGGGCAACAATGTCTAC |
| PpAce2L27 | 1749-1723 (L) | TGTAGAGATACATGTAGACATTGTTGC |
| PpAce22L18 | 1760-1743 (L) | GGTGCGATGGGTGTAGAG |
| PpAce18F-2561 L20 | 2309-2289 (L) | GAGTAAATCGCGTTACTTCA |
aPosition (based on PpAChE sequence numbering, Figure 1).
bSequence is 5’s3’, upper (U) or lower (L) strand.
Figure 1Clustal W 2.1 multiple sequence alignment of AChE protein sequences for [GenBank: JQ922267], [GenBank: ABI74669], AChE [GenBank: Q86GC8], and [GenBank: XP_001656977]. The consensus line below the aligned sequences indicates positions of conserved amino acid identity (*) or similarity (: or .). Positions of the 3 disulfide bond linkages are indicated by numbers above participating cysteine pairs. The members of the catalytic triad (S, E, H) which make up the catalytic site are indicated by (‡) above the participating amino acid.
Biochemical properties of rPpAChE
| 37.9 ± 1.6 | |
| IC50 Paraoxon (10-7 M) | 2.3 (1.9-2.7) |
| IC50 Malaoxon (10-8 M) | 2.7 (1.7-4.5) |
| IC50 Eserine (10-10 M) | 7.2 (5.0-10.5) |
| IC50 BW284c51 (10-8 M) | 7.1 (5.9-8.4) |
| IC50 Ethopropazine (10-6 M) | 4.4 (4.0-4.9) |
| IC50 Iso-OMPA | NCc |
aAcSCh = acetylthiocholine; IC50 = concentration of inhibitor producing 50% inhibition of enzyme activity during 10 min preincubation.
bData are presented as mean ± SE or (95% confidence interval).
c NC = not calculated (no inhibition detected at 10-3 M).